National Cancer Institute; Notice of Closed Meetings, 29769-29770 [2010-12778]

Download as PDF Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices requirements of the applicable statutes and regulations. II. Paperwork Reduction Act of 1995 This guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501– 3520). The collections of information in 21 CFR 601.12 have been approved under OMB control number 0910–0338; the collections of information in 21 CFR 606.100 have been approved under OMB control number 0910–0116; and the collections of information in 21 CFR Part 600.14 and 606.171 have been approved under OMB control number 0910–0458. III. Comments Interested persons may, at any time, submit to the Division of Dockets Management (see ADDRESSES) electronic or written comments regarding the guidance. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. A copy of the guidance and received comments are available for public examination in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. IV. Electronic Access Persons with access to the Internet may obtain the guidance at either https:// www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatory Information/Guidances/default.htm or https://www.regulations.gov. Dated: May 18, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–12696 Filed 5–26–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES wwoods2 on DSK1DXX6B1PROD with NOTICES Agency for Healthcare Research and Quality Notice of Meetings In accordance with section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C., Appendix 2), the Agency for Healthcare Research and Quality (AHRQ) announces meetings of scientific peer review groups. The subcommittees listed below are part of VerDate Mar<15>2010 15:26 May 26, 2010 Jkt 220001 the Agency’s Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications are to be reviewed and discussed at these meetings. These discussions are likely to involve information concerning individuals associated with the applications, including assessments of their personal qualifications to conduct their proposed projects. This information is exempt from mandatory disclosure under the above-cited statutes. 1. Name of Subcommittee: Health Care Technology and Decision Sciences. Date: June 15–17, 2010 (Open from 8 a.m. to 8:15 a.m. on June 15 and closed for remainder of the meeting) Place: Crowne Plaza Hotel, 3 Research Court, Conference Room TBD, Rockville, MD 20852. 2. Name of Subcommittee: Health Systems Research. Date: June 16–18, 2010 (Open from 8 a.m. to 8:15 a.m. on June 16 and closed for remainder of the meeting) Place: Sheraton Rockville Hotel, 920 King Farm Boulevard, Conference Room TBD, Rockville, MD 20852. 3. Name of Subcommittee: Health Care Research Training. Date: June 17–18, 2010 (Open from 8 a.m. to 8:15 a.m. on June 17 and closed for remainder of the meeting) Place: Hyatt Regency Hotel, 7400 Wisconsin Avenue, 1 Bethesda Metro Center, Conference Room TBD, Bethesda, Maryland 20814. 4. Name of Subcommittee: Health Care Quality and Effectiveness Research. Date: June 22–24, 2010 (Open from 8:30 a.m. to 8:45 a.m. on June 22 and closed for remainder of the meeting) Place: Hilton Rockville Executive Meeting Center, 1750 Rockville Pike, Conference Room TBD, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of the meetings should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for these meetings are subject to change as priorities dictate. Dated: May 13, 2010. Carolyn M. Clancy, Director. [FR Doc. 2010–12547 Filed 5–26–10; 8:45 am] BILLING CODE 4160–90–M PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 29769 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Integrating Patient-Reported Outcomes in Hospice and Palliative Care Practices. Date: June 1, 2010. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, 6116 Executive Blvd., Room 8018, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Shamala K. Srinivas, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892, 301–594–1224, ss537t@nih.gov. This notice is being published less than 30 days prior to the meeting due to scheduling conflicts. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Anticancer Agents. Date: June 2, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Room 8018, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Joyce C. Pegues, B.S., B.A., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov. This notice is being published less than 30 days prior to the meeting due to scheduling conflicts. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer E:\FR\FM\27MYN1.SGM 27MYN1 29770 Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 20, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12778 Filed 5–26–10; 8:45 am] submit a request at least 10 days prior to the meeting. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. This phone call may end prior to or later than 12 p.m., depending on the needs of the subcommittees. Information about the IACC is available on the Web site: https://www.iacc.hhs.gov. Dated: May 20, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–12781 Filed 5–26–10; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a joint meeting of the Interagency Autism Coordinating Committee (IACC) Services Subcommittee and the IACC Subcommittee for Planning the Annual Strategic Plan Updating Process. The purpose of the joint meeting between the IACC Services Subcommittee and IACC Subcommittee for Planning the Annual Strategic Plan Updating Process is to discuss plans for a fall 2010 IACC Scientific Workshop on ASD services research. The Subcommittees’ joint meeting will be conducted as a telephone conference call. This meeting is open to the public through a conference call phone number. wwoods2 on DSK1DXX6B1PROD with NOTICES National Institute of Mental Health; Notice of Meeting National Institutes of Health Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of meeting: Joint meeting of the Services Subcommittee and Subcommittee for Planning the Annual Strategic Plan Updating Process. Date: Friday, June 18, 2010. Time: 10 a.m. to 12 p.m. Eastern Time. Agenda: The IACC Services Subcommittee and the IACC Subcommittee for Planning the Annual Strategic Plan Updating Process will discuss plans for a fall 2010 IACC Scientific Workshop on ASD services research. Place: No in-person meeting; conference call only. Conference Call: Dial: 800–369–3340, Access code: 8415008. Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, Office of the Director, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 8200, Bethesda, MD 20852–9669, Phone: (301) 443–6040, E-mail: IACCPublicInquiries@mail.nih.gov. Please Note: The meeting will be open to the public through a conference call phone number. Individuals who participate using this service and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should VerDate Mar<15>2010 19:31 May 26, 2010 Jkt 220001 National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Allergy, Immunology, and Transplantation Research Committee. Date: June 22, 2010. Time: 9 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Zhuqing (Charlie) Li, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–402–9523, zhuqing.li@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: May 20, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12784 Filed 5–26–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Career Development, Research Training & Pathways to Independence Review. Date: June 14, 2010. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Eric H. Brown, PhD, Scientific Review Officer, NIAMS/NIH, 6701 Democracy Blvd., Suite 824, Bethesda, MD 20892, (301) 594–4955, browneri@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: May 20, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12791 Filed 5–26–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting In accordance with section 10 (d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 75, Number 102 (Thursday, May 27, 2010)]
[Notices]
[Pages 29769-29770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Integrating Patient-Reported Outcomes in Hospice and 
Palliative Care Practices.
    Date: June 1, 2010.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, 6116 Executive Blvd., Room 
8018, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8123, Bethesda, MD 20892, 301-594-1224, 
ss537t@nih.gov.
    This notice is being published less than 30 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Anticancer Agents.
    Date: June 2, 2010.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8018, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Joyce C. Pegues, B.S., B.A., PhD, Scientific 
Review Officer, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-
1286, peguesj@mail.nih.gov.
    This notice is being published less than 30 days prior to the 
meeting due to scheduling conflicts.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer

[[Page 29770]]

Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12778 Filed 5-26-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.